Trials / Active Not Recruiting
Active Not RecruitingNCT07274007
Traumatic Injury of Spleen:Laparoscopic Splenectomy Vs Splenic Artery Embolization
Management of Grade III Traumatic Splenic Injury in Hemodynamically Stable Patients ; Laparoscopic Splenectomy Versus Splenic Artery Embolization by Interventional Radiology
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Zagazig University · Other Government
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is selection of the best method in management of grade 3 traumatic Splenic Injury in Hemodynamically Stable Patients thus improving the quality of life and clinical outcome. The main questions it aims to answer are 1. Assess the quality of life and clinical outcome after using laparoscopic Splenectomy in management of grade 3 traumatic Splenic Injury in Hemodynamically Stable Patients 2. Assess the quality of life and clinical outcome after using Splenic Artery Embolization in management of grade 3 traumatic Splenic Injury in Hemodynamically Stable Patients Researchers will compare the quality of life and clinical outcome to see if it is better using laparoscopic Splenectomy Splenic Artery Embolization Participants will underwent laparoscopic Splenectomy or Splenic Artery Embolization and will undwent post operative follow up, follow up at outpatient clinic and will be asked about changes occurring to their daily life social activities and their quality of life
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laparoscopic Splenectomy vs splenic Artery Embolization | Compare the quality of life and clinical outcome after using laparoscopic Splenectomy and Splenic Artery Embolization in management of grade 3 traumatic Splenic Injury in Hemodynamically Stable Patients |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2025-05-31
- Completion
- 2025-11-30
- First posted
- 2025-12-10
- Last updated
- 2025-12-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07274007. Inclusion in this directory is not an endorsement.